Harmony Biosciences Stock Drops Following CFO Resignation
Harmony Biosciences (HRMY) experienced a decline in stock price after the resignation of its Chief Financial Officer, Glenn Reicin. The company appointed Stephen Mollichella as interim principal financial officer to manage operations until a permanent replacement is found.
Tickers: $HRMY